Incyte (INCY) Capital Expenditures (QoQ) (2010 - 2026)
Incyte (INCY) Capital Expenditures (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105.09% |
| Dec 31, 2025 | -197.32% |
| Sep 30, 2025 | 2,749.83% |
| Jun 30, 2025 | -60.00% |
| Mar 31, 2025 | -96.51% |
| Dec 31, 2024 | 2,921.37% |
| Sep 30, 2024 | 556.59% |
| Jun 30, 2024 | 8.88% |
| Mar 31, 2024 | 101.52% |
| Dec 31, 2023 | -197.55% |
| Sep 30, 2023 | 1,795.59% |
| Jun 30, 2023 | -55.51% |
| Mar 31, 2023 | 157.25% |
| Dec 31, 2022 | -4,506.03% |
| Sep 30, 2022 | 98.30% |
| Jun 30, 2022 | -143.21% |
| Mar 31, 2022 | -54.26% |
| Dec 31, 2021 | -70.22% |
| Sep 30, 2021 | 770.45% |
| Jun 30, 2021 | -135.90% |